EcoDrugPlus

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSPVAG00000015183
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSPVAG00000009289
Gene Symbol: ALOX5
1 Cross references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSPVAG00000006157
Gene Symbol: ALOX5AP
1 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSPVAG00000003341
Gene Symbol: AVPR1A
1 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSPVAG00000000724
Gene Symbol: AVPR1B
1 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPVAG00000000461
Gene Symbol: AVPR2
1 Cross references
231 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSPVAG00000002167
Gene Symbol: AHR
1 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSPVAG00000003252
Gene Symbol: AURKA
1 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSPVAG00000016378
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSPVAG00000015550
Gene Symbol: AURKC
1 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSPVAG00000002066
Gene Symbol: BACE1
1 Cross references
217 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSPVAG00000006537
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).